Once-weekly insulin vs once-weekly tirzepatide demonstrated superior safety profiles but inferior weight loss and glycemic control outcomes.

Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...

Nearly 86 per cent of those with type 2 diabetes have been treated with a new procedure that no longer requires insulin, a ...

The FTC sued pharmacy benefit managers over their roles in increasing insulin prices over the past decade. The News talked to ...

A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...